Free shipping on all orders over $ 500

Mesdopetam hemitartrate

Cat. No. M29709

All AbMole products are for research use only, cannot be used for human consumption.

Mesdopetam hemitartrate Structure
Synonym:

IRL790 hemitartrate

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Mesdopetam (IRL790) hemitartrate is a dopamine D3 receptor antagonist (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor) with psychomotor stabilizing properties. Mesdopetam hemitartrate is used for the research of motor and psychiatric complications in Parkinson disease.

Chemical Information
Molecular Weight 700.77
Formula C12H18FNO3S.1/2C4H6O6
CAS Number 2562346-14-7
Form Solid
Solubility (25°C) Water 100 mg/mL (ultrasonic)
DMSO 20.83 mg/mL (ultrasonic and warming and heat to 60°C)
Storage 4°C, dry, sealed
Related Dopamine Receptor Products
AJ-76

AJ-76 ((+)-AJ 76; (1S,2R)-AJ 76) is a dopamine autoreceptor antagonist.

A-412997 

A-412997 is a selective Dopamine D4 agonist with Ki values of 12 and 7.9 nM for the rat and human receptors.

SKF 81297 

SKF 81297 is a potent and selective dopamine D1 receptor agonist.

GBR 12783 

GBR 12783 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively.

RMI-61140 

RMI-61140 is an orally active neuroleptics.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mesdopetam hemitartrate, IRL790 hemitartrate supplier, Dopamine Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.